Carl T Redemann

Title: The Innovative Contributions of Carl T. Redemann

Introduction

Carl T. Redemann is a notable inventor based in Walnut Creek, California, recognized for his significant contributions to the field of liposome technology. With a total of eight patents to his name, Redemann has focused on developing advanced therapeutic compositions that enhance the delivery of medicinal compounds.

Latest Patents

Among his latest patents is the "Microreservoir Liposome Composition and Method." This innovative liposome composition is designed for the extended release of therapeutic compounds into the bloodstream. The liposomes are formulated with vesicle-forming lipids and a specific percentage of a lipid derivatized with a hydrophilic polymer. They are engineered to have sizes ranging from 0.1 to 0.4 microns and contain the therapeutic compound in an entrapped form. This composition allows for a dosage that is three times the amount required for intravenous injection in free form, extending the therapeutic activity of the compound in the bloodstream for at least 24 hours.

Another significant patent is the "Solid Tumor Treatment Method and Composition." This invention focuses on localizing an anti-tumor compound to a solid tumor via the bloodstream. The liposomes in this composition are designed to encapsulate the anti-tumor agent and are composed of vesicle-forming lipids with a biocompatible polymer. They have sizes between 0.07 and 0.12 microns and are taken up by the tumor within 24 to 48 hours after intravenous administration. This method has shown promising results in regressing solid colon and breast carcinomas that are resistant to conventional treatments.

Career Highlights

Throughout his career, Carl T. Redemann has worked with prominent companies such as Liposome Technology, Inc. and The Dow Chemical Company. His work has significantly advanced the understanding and application of liposome technology in therapeutic settings.

Collaborations

Redemann has collaborated with notable professionals in his field, including Annie Yau-Young and Martin C. Woodle. These collaborations have contributed to the development of innovative solutions in drug delivery systems.

Conclusion

Carl T. Redemann's contributions to liposome technology and therapeutic compositions have made a lasting impact on the medical field. His innovative patents continue to pave the way for advancements in drug delivery and cancer treatment.